Search results
Multiple sclerosis stem cell treatment breakthrough could stop disease in its tracks, study finds
The Independent via Yahoo News· 7 months agoA breakthrough in stem cell research has provided a glimmer of hope for a new treatment that could...
1st-of-its-kind therapy blocks immune attack after stem-cell transplant
Live Science via Yahoo News· 5 months agoSurgeon monitors the extraction of bone marrow from a patient using a giant syringe in the operating...
Trial to assess best course of treatment for patients with MS
Press Association News via AOL· 2 years agoScientists are to assess the best course of treatment for various types of multiple sclerosis in a...
What to Know About Hunter Syndrome (MPS II)
Verywell Health via Yahoo News· 11 months agoThis Rare Genetic Condition Mostly Affects Males tatyana_tomsickova / Getty Images Medically reviewed by Jonathan B. Jassey, DO Hunter syndrome aka...
HC Wainwright Says Talaris' Technology Unprecedented In Cell Therapy Space
Benzinga via Yahoo Finance· 2 years agoHC Wainwright initiated coverage on Talaris Therapeutics Inc (NASDAQ: TALS) with a Buy rating and a...
NexImmune Shifts Focus On AIM Direct Injection Platform, Potential Candidates In Oncology &...
Benzinga via Yahoo Finance· 2 years agoNexImmune Inc (NASDAQ: NEXI) announced the realignment of R&D resources to focus on the AIM Direct...
Selma Blair shares new details of life with MS in remission: 'It haunts my physical cells'
The Today Show via AOL· 1 year agoSince Selma Blair first revealed her diagnosis publicly in 2018, she’s been open about her...
I‘m a Runner, and My MS Has Made Me More Determined Than Ever
Prevention via Yahoo News· 2 years agoMarathon runner Sagirah Amed Norris shares how getting diagnosed with MS, an invisible disability,...
Selma Blair gives update on MS remission: ‘I hurt all the time'
TODAY via Yahoo News· 5 months agoSelma Blair's multiple sclerosis is still in remission, but she does have day-to-day struggles as a...
GlycoMimetics (GLYC) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoGood morning, and thank you for joining the GlycoMimetics Q2 2022 earnings call. Brian will then...